277 related articles for article (PubMed ID: 21923247)
1. Prospective evaluation of the characteristics and incidence of adenoma-associated dural invasion in Cushing disease.
Lonser RR; Ksendzovsky A; Wind JJ; Vortmeyer AO; Oldfield EH
J Neurosurg; 2012 Feb; 116(2):272-9. PubMed ID: 21923247
[TBL] [Abstract][Full Text] [Related]
2. Basis of persistent and recurrent Cushing disease: an analysis of findings at repeated pituitary surgery.
Dickerman RD; Oldfield EH
J Neurosurg; 2002 Dec; 97(6):1343-9. PubMed ID: 12507132
[TBL] [Abstract][Full Text] [Related]
3. Invasion of the corticotrophs.
Mayberg MR
J Neurosurg; 2012 Feb; 116(2):269-71; discussion 270-1. PubMed ID: 21923245
[No Abstract] [Full Text] [Related]
4. Outcome of surgical treatment of 200 children with Cushing's disease.
Lonser RR; Wind JJ; Nieman LK; Weil RJ; DeVroom HL; Oldfield EH
J Clin Endocrinol Metab; 2013 Mar; 98(3):892-901. PubMed ID: 23372173
[TBL] [Abstract][Full Text] [Related]
5. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.
Meij BP; Lopes MB; Ellegala DB; Alden TD; Laws ER
J Neurosurg; 2002 Feb; 96(2):195-208. PubMed ID: 11838791
[TBL] [Abstract][Full Text] [Related]
6. Ectopic Adrenocorticotropic Hormone-Secreting Pituitary Adenomas: An Underestimated Entity.
Knappe UJ; Jaspers C; Buschsieweke D; Reinbold WD; Alomari A; Saeger W; Ehlenz K; Mann WA; Kann PH; Feldkamp J
Neurosurgery; 2017 Apr; 80(4):525-533. PubMed ID: 27352274
[TBL] [Abstract][Full Text] [Related]
7. High-resolution(18)F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for pituitary adenoma detection in Cushing disease.
Chittiboina P; Montgomery BK; Millo C; Herscovitch P; Lonser RR
J Neurosurg; 2015 Apr; 122(4):791-7. PubMed ID: 25479121
[TBL] [Abstract][Full Text] [Related]
8. MR imaging of cavernous sinus involvement by pituitary adenomas.
Scotti G; Yu CY; Dillon WP; Norman D; Colombo N; Newton TH; De Groot J; Wilson CB
AJR Am J Roentgenol; 1988 Oct; 151(4):799-806. PubMed ID: 3262283
[TBL] [Abstract][Full Text] [Related]
9. Cavernous sinus invasion by pituitary adenomas--relationship between magnetic resonance imaging findings and histologically verified dural invasion.
Daita G; Yonemasu Y; Nakai H; Takei H; Ogawa K
Neurol Med Chir (Tokyo); 1995 Jan; 35(1):17-21. PubMed ID: 7700477
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic Extracapsular Resection of an Adrenocorticotropic Hormone-Secreting Macroadenoma with Selective Resection of the Medial Cavernous Sinus Wall.
Borghei-Razavi H; Muhsen BA; Joshi K; Woodard T; Kshettry VR
World Neurosurg; 2020 Dec; 144():199. PubMed ID: 32971280
[TBL] [Abstract][Full Text] [Related]
11. Ectopic ACTH-secreting pituitary adenoma of the sphenoid sinus: case report of endoscopic endonasal resection and systematic review of the literature.
Seltzer J; Lucas J; Commins D; Lerner O; Lerner A; Carmichael JD; Zada G
Neurosurg Focus; 2015 Feb; 38(2):E10. PubMed ID: 25639312
[TBL] [Abstract][Full Text] [Related]
12. Aggressive transsphenoidal resection of tumors invading the cavernous sinus in patients with acromegaly: predictive factors, strategies, and outcomes.
Nishioka H; Fukuhara N; Horiguchi K; Yamada S
J Neurosurg; 2014 Sep; 121(3):505-10. PubMed ID: 25014437
[TBL] [Abstract][Full Text] [Related]
13. Cushing's disease and dural invasion.
Hueng DY; Ma HI; Chen CM
J Neurosurg; 2012 Jul; 117(1):189-90; author reply 190-1. PubMed ID: 22577750
[No Abstract] [Full Text] [Related]
14. Endoscopic Endonasal Approach to Multilobular Giant Pituitary Adenoma with Cavernous Sinus Invasion and Petroclival Extension.
Rahimli T; Hidayetov T; Rajabov T
World Neurosurg; 2021 Mar; 147():128-129. PubMed ID: 33220473
[TBL] [Abstract][Full Text] [Related]
15. Clinical Parameters to Distinguish Silent Corticotroph Adenomas from Other Nonfunctioning Pituitary Adenomas.
Kim D; Ku CR; Park SH; Moon JH; Kim EH; Kim SH; Lee EJ
World Neurosurg; 2018 Jul; 115():e464-e471. PubMed ID: 29678704
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
17. Orbital invasion by ACTH-secreting pituitary adenomas.
Dhaliwal JS; Seibold LK; Kleinschmidt-Demasters BK; Lillehei KO; Hink EM; Prall JA; Durairaj VD
Ophthalmic Plast Reconstr Surg; 2014; 30(2):e28-30. PubMed ID: 23645353
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of composite methionine-positron emission tomography/3.0-tesla magnetic resonance imaging to detect the localization and extent of early-stage Cushing adenoma.
Ikeda H; Abe T; Watanabe K
J Neurosurg; 2010 Apr; 112(4):750-5. PubMed ID: 19698042
[TBL] [Abstract][Full Text] [Related]
19. Current state of the art in the diagnosis and surgical treatment of Cushing disease: early experience with a purely endoscopic endonasal technique.
Dehdashti AR; Gentili F
Neurosurg Focus; 2007; 23(3):E9. PubMed ID: 17961027
[TBL] [Abstract][Full Text] [Related]
20. Somatic USP8 Gene Mutations Are a Common Cause of Pediatric Cushing Disease.
Faucz FR; Tirosh A; Tatsi C; Berthon A; Hernández-RamÃrez LC; Settas N; Angelousi A; Correa R; Papadakis GZ; Chittiboina P; Quezado M; Pankratz N; Lane J; Dimopoulos A; Mills JL; Lodish M; Stratakis CA
J Clin Endocrinol Metab; 2017 Aug; 102(8):2836-2843. PubMed ID: 28505279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
